Two scientists, a philosopher and an economist from the University have received some of the most prestigious honors their peers can bestow.
William K. DeGrado
Ralph F. Hirschmann
David Cass
Paul Guyer
The two scientists - Ralph F. Hirschmann, Ph.D., and William F. DeGrado, Ph.D. - were among the 60 members recently named to the National Academy of Sciences.
Economist David Cass, Ph.D., was elected Distinguished Fellow of the American Economic Association - one of only two this year.
And Paul Guyer, Ph.D., was elected a Fellow of the American Academy of Arts and Sciences.
DeGrado, professor of biochemistry and biophysics in the School of Medicine, is known for designing new kinds of proteins and peptides.
Hirschmann, Makineni Chair of Bioorganic Chemistry, is known for chemical synthesis of molecules that have pharmaceutical applications, such as anti-inflammatory steroids.
Cass, with research interests in pure theory of capital, individual behavior under uncertainty and models of financial equilibrium, is the Miller Professor Economics and director of the Center for Analytic Research in Economics and the Social Sciences (CARESS).
Guyer, Murray Professor in the Humanities and professor of psychology, and one of the world's most eminent Immanuel Kant scholars, has written and edited or translated nine books on Kant, including a new translation of Kant's "Critique of Pure Reason," the seminal work of modern philosophy.
Penn physicists led by Bo Zhen have created hybrid light-matter particles that interact strongly enough to compute, pointing toward ultrafast, low-energy optical AI hardware.
Penn’s newest supercomputer is transforming research
Penn’s first campus-wide HPC and AI cluster, “Betty,” is expanding access to powerful computing, enabling groundbreaking projects, and fostering new collaborations across disciplines.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
The performing arts at Penn: Process, practice, and purpose
In the vivid tapestry of performing arts groups at Penn, students prepare for their performances while simultaneously enriching their college experience.
